Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial
Bruce E. Sands(Icahn School of Medicine at Mount Sinai), Olga Fedorishina, Karen A. Chachu(Washington University in St. Louis), Mauro Bafutto, Fraser Cummings, Ellen Scherl(NewYork–Presbyterian Hospital), О. Б. Щукина(City Clinical Hospital No 31), Remo Panaccione(University of Calgary), Christopher Gasink(Janssen (United States)), Andrew Greenspan(Janssen (United States)), Stephen B. Hanauer(Northwestern University), Jésus Barrio, Monika Augustyn, Guillaume Bonnaud, Tanja Kuehbacher, Júlio Maria Fonseca Chebli, Halina Cichoż‐Lach, Peter M. Irving(Guy's and St Thomas' NHS Foundation Trust), Anita Afzali, William J. Sandborn(University of San Diego), Vipul Jairath(McMaster University), Xavier Aldeguer i Mante, James D. Lewis(University of Pennsylvania), Jakob Begun, Lilia Aitova, Silvio Danese(IRCCS Ospedale San Raffaele), Matthieu Allez(Inserm), Xavier Calvet(Universitat Autònoma de Barcelona), Marija Branković(University of Belgrade), Edward V. Loftus(Mayo Clinic), Alessandro Armuzzi, Jae Hee Cheon(Severance Hospital), Ik Jang Byung, Clint Behrend, George Duvall, Étienne Désilets, James Izanec(Janssen (United States)), Federico Argüelles‐Arias, Predrag Dugalić, Long-Long Gao(Janssen (United States)), Maria de Lourdes Abreu Ferrari, Timothy Hoops(Johnson & Johnson (United States)), Larry Clark(Costello Medical Consulting (United Kingdom)), Emese Mihály(Semmelweis University), I Altorjay, Nanne K.H. de Boer, Kunal Dalal, Geert Bezemer
Cited by 295
Related Papers
Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes
|Science|2011|6.6k
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
|Nature Medicine|2013|4.4k
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
|Genome biology|2012|2.8k